Cell line · CVCL_1279
HGC-27
Cancer cell line, Homo sapiens. Gastric carcinoma. 69 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. HGC-27. Cell lines, record CVCL_1279. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1279
On this page
Cell line
As Cellosaurus gives it.
- Name
- HGC-27
- Accession
- CVCL_1279
- RRID
- RRID:CVCL_1279
- Synonyms
- HGC 27, HGC27
- Species
- Homo sapiens (Human)
- Sex
- Sex unspecified
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Gastric carcinoma (NCIt C4911)
- Derived from
- Lymph node (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers69
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Epigenetic Activation of ANGPTL4 Drives EBV-Negative Gastric Cancer via Neutrophil Recruitment and NET Release via Stabilizing ANXA5. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Enhanced Antitumor Effects of 5-Fluorouracil and a Vagal Nerve Blocker Loaded in a Thermosensitive Hydrogel for Localized Drug Delivery in Gastric Cancer. | Pharmaceutics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calcitriol alleviates ARID2-deficient gastric cancer metastasis via inhibition of the Wnt/β-catenin signaling pathway. | Transl Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Discovery and Optimization of AMT-676, a CDH17-Targeting ADC for the Treatment of Advanced Gastrointestinal Cancers. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mutation-Immune Crosstalk Contextualizes CAF-Associated ARPC1A Programs and Cisplatin Response in Gastric Cancer. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| METTL7A Downregulation Drives SLC1A5-Mediated Glutamine Competition to Promote Tumor Proliferation and Suppress CD8+ T Cell Immunity in Gastric Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TMEM97 regulates cholesterol biosynthesis and mitochondrial metabolism in gastric carcinoma. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Long non-coding RNA SOCS2-AS1 inhibits gastric cancer progression via the miR-324-3p/GRIK3 axis: a mechanistic study. | World J Surg Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of 5'-tiRNAGly restores anti-PD-1 immunotherapy efficacy via DLST-mediated OGDHL succinylation in gastric cancer. | J Exp Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 69
See all 69 papersRelatives15
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE HGC27-CopGFP | CVCL_F6A9 | Cell lines | |
| Derived from it | EDITGENE HGC27-FLUC | CVCL_F5SV | Cell lines | |
| Derived from it | HGC27-EGFP | CVCL_XB28 | Cell lines | |
| Derived from it | HGC27-mCherry-2 | CVCL_XD65 | Cell lines | |
| Derived from it | HGC27-tdT | CVCL_XB29 | Cell lines | |
| Derived from it | HyCyte HGC-27 KO-hERV3-1 | CVCL_F4EU | Cell lines | |
| Derived from it | HyCyte HGC-27 KO-hHKDC1 | CVCL_F1QF | Cell lines | |
| Derived from it | HyCyte HGC-27 KO-hLIN28B | CVCL_F1QG | Cell lines | |
| Derived from it | HyCyte HGC-27 KO-hPIN1 | CVCL_F1QH | Cell lines | |
| Derived from it | HyCyte HGC-27 KO-hZC3H13 | CVCL_F1QI | Cell lines |
1 to 10 of 15
See all 15 relativesCell banks9
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1279
GET https://conductscience.org/api/cell-lines/v1/CVCL_1279/papers?page=2